Global Coagulation Albumin Market Growth 2025-2031

October 2025 | 111 pages | ID: G166AF838494EN
LP Information

Abstracts

The global Coagulation Albumin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Coagulation Albumin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Coagulation Albumin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Coagulation Albumin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Coagulation Albumin players cover Baxter, Grifols, CSL, Octapharma, Biotest, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Coagulation Albumin Industry Forecast? looks at past sales and reviews total world Coagulation Albumin sales in 2024, providing a comprehensive analysis by region and market sector of projected Coagulation Albumin sales for 2025 through 2031. With Coagulation Albumin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coagulation Albumin industry.

This Insight Report provides a comprehensive analysis of the global Coagulation Albumin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coagulation Albumin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Coagulation Albumin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coagulation Albumin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coagulation Albumin.

This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Albumin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Liquid Coagulation Albumin
• Powder Coagulation Albumin

Segmentation by Application:

• Infectious Hepatitis
• Measles
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Baxter
• Grifols
• CSL
• Octapharma
• Biotest
• Kedrion
• Hualan Bio
• CNBG
• Shanghai RAAS
• CBPO
• LFB Group
• BPL
• Sichuan Yuanda Shuyang

Key Questions Addressed in this Report

What is the 10-year outlook for the global Coagulation Albumin market?
What factors are driving Coagulation Albumin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Coagulation Albumin market opportunities vary by end market size?
How does Coagulation Albumin break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Coagulation Albumin Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Coagulation Albumin by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Coagulation Albumin by Country/Region, 2020, 2024 & 2031
2.2 Coagulation Albumin Segment by Type
  2.2.1 Liquid Coagulation Albumin
  2.2.2 Powder Coagulation Albumin
2.3 Coagulation Albumin Sales by Type
  2.3.1 Global Coagulation Albumin Sales Market Share by Type (2020-2025)
  2.3.2 Global Coagulation Albumin Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Coagulation Albumin Sale Price by Type (2020-2025)
2.4 Coagulation Albumin Segment by Application
  2.4.1 Infectious Hepatitis
  2.4.2 Measles
  2.4.3 Other
2.5 Coagulation Albumin Sales by Application
  2.5.1 Global Coagulation Albumin Sale Market Share by Application (2020-2025)
  2.5.2 Global Coagulation Albumin Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Coagulation Albumin Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Coagulation Albumin Breakdown Data by Company
  3.1.1 Global Coagulation Albumin Annual Sales by Company (2020-2025)
  3.1.2 Global Coagulation Albumin Sales Market Share by Company (2020-2025)
3.2 Global Coagulation Albumin Annual Revenue by Company (2020-2025)
  3.2.1 Global Coagulation Albumin Revenue by Company (2020-2025)
  3.2.2 Global Coagulation Albumin Revenue Market Share by Company (2020-2025)
3.3 Global Coagulation Albumin Sale Price by Company
3.4 Key Manufacturers Coagulation Albumin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Coagulation Albumin Product Location Distribution
  3.4.2 Players Coagulation Albumin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR COAGULATION ALBUMIN BY GEOGRAPHIC REGION

4.1 World Historic Coagulation Albumin Market Size by Geographic Region (2020-2025)
  4.1.1 Global Coagulation Albumin Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Coagulation Albumin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Coagulation Albumin Market Size by Country/Region (2020-2025)
  4.2.1 Global Coagulation Albumin Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Coagulation Albumin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Coagulation Albumin Sales Growth
4.4 APAC Coagulation Albumin Sales Growth
4.5 Europe Coagulation Albumin Sales Growth
4.6 Middle East & Africa Coagulation Albumin Sales Growth

5 AMERICAS

5.1 Americas Coagulation Albumin Sales by Country
  5.1.1 Americas Coagulation Albumin Sales by Country (2020-2025)
  5.1.2 Americas Coagulation Albumin Revenue by Country (2020-2025)
5.2 Americas Coagulation Albumin Sales by Type (2020-2025)
5.3 Americas Coagulation Albumin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Coagulation Albumin Sales by Region
  6.1.1 APAC Coagulation Albumin Sales by Region (2020-2025)
  6.1.2 APAC Coagulation Albumin Revenue by Region (2020-2025)
6.2 APAC Coagulation Albumin Sales by Type (2020-2025)
6.3 APAC Coagulation Albumin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Coagulation Albumin by Country
  7.1.1 Europe Coagulation Albumin Sales by Country (2020-2025)
  7.1.2 Europe Coagulation Albumin Revenue by Country (2020-2025)
7.2 Europe Coagulation Albumin Sales by Type (2020-2025)
7.3 Europe Coagulation Albumin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Coagulation Albumin by Country
  8.1.1 Middle East & Africa Coagulation Albumin Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Coagulation Albumin Revenue by Country (2020-2025)
8.2 Middle East & Africa Coagulation Albumin Sales by Type (2020-2025)
8.3 Middle East & Africa Coagulation Albumin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coagulation Albumin
10.3 Manufacturing Process Analysis of Coagulation Albumin
10.4 Industry Chain Structure of Coagulation Albumin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Coagulation Albumin Distributors
11.3 Coagulation Albumin Customer

12 WORLD FORECAST REVIEW FOR COAGULATION ALBUMIN BY GEOGRAPHIC REGION

12.1 Global Coagulation Albumin Market Size Forecast by Region
  12.1.1 Global Coagulation Albumin Forecast by Region (2026-2031)
  12.1.2 Global Coagulation Albumin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Coagulation Albumin Forecast by Type (2026-2031)
12.7 Global Coagulation Albumin Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Baxter
  13.1.1 Baxter Company Information
  13.1.2 Baxter Coagulation Albumin Product Portfolios and Specifications
  13.1.3 Baxter Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Baxter Main Business Overview
  13.1.5 Baxter Latest Developments
13.2 Grifols
  13.2.1 Grifols Company Information
  13.2.2 Grifols Coagulation Albumin Product Portfolios and Specifications
  13.2.3 Grifols Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Grifols Main Business Overview
  13.2.5 Grifols Latest Developments
13.3 CSL
  13.3.1 CSL Company Information
  13.3.2 CSL Coagulation Albumin Product Portfolios and Specifications
  13.3.3 CSL Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 CSL Main Business Overview
  13.3.5 CSL Latest Developments
13.4 Octapharma
  13.4.1 Octapharma Company Information
  13.4.2 Octapharma Coagulation Albumin Product Portfolios and Specifications
  13.4.3 Octapharma Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Octapharma Main Business Overview
  13.4.5 Octapharma Latest Developments
13.5 Biotest
  13.5.1 Biotest Company Information
  13.5.2 Biotest Coagulation Albumin Product Portfolios and Specifications
  13.5.3 Biotest Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Biotest Main Business Overview
  13.5.5 Biotest Latest Developments
13.6 Kedrion
  13.6.1 Kedrion Company Information
  13.6.2 Kedrion Coagulation Albumin Product Portfolios and Specifications
  13.6.3 Kedrion Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Kedrion Main Business Overview
  13.6.5 Kedrion Latest Developments
13.7 Hualan Bio
  13.7.1 Hualan Bio Company Information
  13.7.2 Hualan Bio Coagulation Albumin Product Portfolios and Specifications
  13.7.3 Hualan Bio Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Hualan Bio Main Business Overview
  13.7.5 Hualan Bio Latest Developments
13.8 CNBG
  13.8.1 CNBG Company Information
  13.8.2 CNBG Coagulation Albumin Product Portfolios and Specifications
  13.8.3 CNBG Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 CNBG Main Business Overview
  13.8.5 CNBG Latest Developments
13.9 Shanghai RAAS
  13.9.1 Shanghai RAAS Company Information
  13.9.2 Shanghai RAAS Coagulation Albumin Product Portfolios and Specifications
  13.9.3 Shanghai RAAS Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Shanghai RAAS Main Business Overview
  13.9.5 Shanghai RAAS Latest Developments
13.10 CBPO
  13.10.1 CBPO Company Information
  13.10.2 CBPO Coagulation Albumin Product Portfolios and Specifications
  13.10.3 CBPO Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 CBPO Main Business Overview
  13.10.5 CBPO Latest Developments
13.11 LFB Group
  13.11.1 LFB Group Company Information
  13.11.2 LFB Group Coagulation Albumin Product Portfolios and Specifications
  13.11.3 LFB Group Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 LFB Group Main Business Overview
  13.11.5 LFB Group Latest Developments
13.12 BPL
  13.12.1 BPL Company Information
  13.12.2 BPL Coagulation Albumin Product Portfolios and Specifications
  13.12.3 BPL Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 BPL Main Business Overview
  13.12.5 BPL Latest Developments
13.13 Sichuan Yuanda Shuyang
  13.13.1 Sichuan Yuanda Shuyang Company Information
  13.13.2 Sichuan Yuanda Shuyang Coagulation Albumin Product Portfolios and Specifications
  13.13.3 Sichuan Yuanda Shuyang Coagulation Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Sichuan Yuanda Shuyang Main Business Overview
  13.13.5 Sichuan Yuanda Shuyang Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Coagulation Albumin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Coagulation Albumin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid Coagulation Albumin
Table 4. Major Players of Powder Coagulation Albumin
Table 5. Global Coagulation Albumin Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Coagulation Albumin Sales Market Share by Type (2020-2025)
Table 7. Global Coagulation Albumin Revenue by Type (2020-2025) & ($ million)
Table 8. Global Coagulation Albumin Revenue Market Share by Type (2020-2025)
Table 9. Global Coagulation Albumin Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Coagulation Albumin Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Coagulation Albumin Sale Market Share by Application (2020-2025)
Table 12. Global Coagulation Albumin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Coagulation Albumin Revenue Market Share by Application (2020-2025)
Table 14. Global Coagulation Albumin Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Coagulation Albumin Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Coagulation Albumin Sales Market Share by Company (2020-2025)
Table 17. Global Coagulation Albumin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Coagulation Albumin Revenue Market Share by Company (2020-2025)
Table 19. Global Coagulation Albumin Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Coagulation Albumin Producing Area Distribution and Sales Area
Table 21. Players Coagulation Albumin Products Offered
Table 22. Coagulation Albumin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Coagulation Albumin Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Coagulation Albumin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Coagulation Albumin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Coagulation Albumin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Coagulation Albumin Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Coagulation Albumin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Coagulation Albumin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Coagulation Albumin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Coagulation Albumin Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Coagulation Albumin Sales Market Share by Country (2020-2025)
Table 35. Americas Coagulation Albumin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Coagulation Albumin Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Coagulation Albumin Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Coagulation Albumin Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Coagulation Albumin Sales Market Share by Region (2020-2025)
Table 40. APAC Coagulation Albumin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Coagulation Albumin Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Coagulation Albumin Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Coagulation Albumin Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Coagulation Albumin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Coagulation Albumin Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Coagulation Albumin Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Coagulation Albumin Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Coagulation Albumin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Coagulation Albumin Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Coagulation Albumin Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Coagulation Albumin
Table 52. Key Market Challenges & Risks of Coagulation Albumin
Table 53. Key Industry Trends of Coagulation Albumin
Table 54. Coagulation Albumin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Coagulation Albumin Distributors List
Table 57. Coagulation Albumin Customer List
Table 58. Global Coagulation Albumin Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Coagulation Albumin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Coagulation Albumin Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Coagulation Albumin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Coagulation Albumin Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Coagulation Albumin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Coagulation Albumin Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Coagulation Albumin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Coagulation Albumin Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Coagulation Albumin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Coagulation Albumin Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Coagulation Albumin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Coagulation Albumin Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Coagulation Albumin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Baxter Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 73. Baxter Coagulation Albumin Product Portfolios and Specifications
Table 74. Baxter Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Baxter Main Business
Table 76. Baxter Latest Developments
Table 77. Grifols Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 78. Grifols Coagulation Albumin Product Portfolios and Specifications
Table 79. Grifols Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Grifols Main Business
Table 81. Grifols Latest Developments
Table 82. CSL Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 83. CSL Coagulation Albumin Product Portfolios and Specifications
Table 84. CSL Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. CSL Main Business
Table 86. CSL Latest Developments
Table 87. Octapharma Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 88. Octapharma Coagulation Albumin Product Portfolios and Specifications
Table 89. Octapharma Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Octapharma Main Business
Table 91. Octapharma Latest Developments
Table 92. Biotest Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 93. Biotest Coagulation Albumin Product Portfolios and Specifications
Table 94. Biotest Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. Biotest Main Business
Table 96. Biotest Latest Developments
Table 97. Kedrion Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 98. Kedrion Coagulation Albumin Product Portfolios and Specifications
Table 99. Kedrion Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Kedrion Main Business
Table 101. Kedrion Latest Developments
Table 102. Hualan Bio Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 103. Hualan Bio Coagulation Albumin Product Portfolios and Specifications
Table 104. Hualan Bio Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 105. Hualan Bio Main Business
Table 106. Hualan Bio Latest Developments
Table 107. CNBG Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 108. CNBG Coagulation Albumin Product Portfolios and Specifications
Table 109. CNBG Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 110. CNBG Main Business
Table 111. CNBG Latest Developments
Table 112. Shanghai RAAS Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 113. Shanghai RAAS Coagulation Albumin Product Portfolios and Specifications
Table 114. Shanghai RAAS Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 115. Shanghai RAAS Main Business
Table 116. Shanghai RAAS Latest Developments
Table 117. CBPO Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 118. CBPO Coagulation Albumin Product Portfolios and Specifications
Table 119. CBPO Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 120. CBPO Main Business
Table 121. CBPO Latest Developments
Table 122. LFB Group Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 123. LFB Group Coagulation Albumin Product Portfolios and Specifications
Table 124. LFB Group Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 125. LFB Group Main Business
Table 126. LFB Group Latest Developments
Table 127. BPL Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 128. BPL Coagulation Albumin Product Portfolios and Specifications
Table 129. BPL Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 130. BPL Main Business
Table 131. BPL Latest Developments
Table 132. Sichuan Yuanda Shuyang Basic Information, Coagulation Albumin Manufacturing Base, Sales Area and Its Competitors
Table 133. Sichuan Yuanda Shuyang Coagulation Albumin Product Portfolios and Specifications
Table 134. Sichuan Yuanda Shuyang Coagulation Albumin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 135. Sichuan Yuanda Shuyang Main Business
Table 136. Sichuan Yuanda Shuyang Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Coagulation Albumin
Figure 2. Coagulation Albumin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Coagulation Albumin Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Coagulation Albumin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Coagulation Albumin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Coagulation Albumin Sales Market Share by Country/Region (2024)
Figure 10. Coagulation Albumin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid Coagulation Albumin
Figure 12. Product Picture of Powder Coagulation Albumin
Figure 13. Global Coagulation Albumin Sales Market Share by Type in 2025
Figure 14. Global Coagulation Albumin Revenue Market Share by Type (2020-2025)
Figure 15. Coagulation Albumin Consumed in Infectious Hepatitis
Figure 16. Global Coagulation Albumin Market: Infectious Hepatitis (2020-2025) & (K Pcs)
Figure 17. Coagulation Albumin Consumed in Measles
Figure 18. Global Coagulation Albumin Market: Measles (2020-2025) & (K Pcs)
Figure 19. Coagulation Albumin Consumed in Other
Figure 20. Global Coagulation Albumin Market: Other (2020-2025) & (K Pcs)
Figure 21. Global Coagulation Albumin Sale Market Share by Application (2024)
Figure 22. Global Coagulation Albumin Revenue Market Share by Application in 2025
Figure 23. Coagulation Albumin Sales by Company in 2025 (K Pcs)
Figure 24. Global Coagulation Albumin Sales Market Share by Company in 2025
Figure 25. Coagulation Albumin Revenue by Company in 2025 ($ millions)
Figure 26. Global Coagulation Albumin Revenue Market Share by Company in 2025
Figure 27. Global Coagulation Albumin Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Coagulation Albumin Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Coagulation Albumin Sales 2020-2025 (K Pcs)
Figure 30. Americas Coagulation Albumin Revenue 2020-2025 ($ millions)
Figure 31. APAC Coagulation Albumin Sales 2020-2025 (K Pcs)
Figure 32. APAC Coagulation Albumin Revenue 2020-2025 ($ millions)
Figure 33. Europe Coagulation Albumin Sales 2020-2025 (K Pcs)
Figure 34. Europe Coagulation Albumin Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Coagulation Albumin Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Coagulation Albumin Revenue 2020-2025 ($ millions)
Figure 37. Americas Coagulation Albumin Sales Market Share by Country in 2025
Figure 38. Americas Coagulation Albumin Revenue Market Share by Country (2020-2025)
Figure 39. Americas Coagulation Albumin Sales Market Share by Type (2020-2025)
Figure 40. Americas Coagulation Albumin Sales Market Share by Application (2020-2025)
Figure 41. United States Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Coagulation Albumin Sales Market Share by Region in 2025
Figure 46. APAC Coagulation Albumin Revenue Market Share by Region (2020-2025)
Figure 47. APAC Coagulation Albumin Sales Market Share by Type (2020-2025)
Figure 48. APAC Coagulation Albumin Sales Market Share by Application (2020-2025)
Figure 49. China Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 53. India Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Coagulation Albumin Sales Market Share by Country in 2025
Figure 57. Europe Coagulation Albumin Revenue Market Share by Country (2020-2025)
Figure 58. Europe Coagulation Albumin Sales Market Share by Type (2020-2025)
Figure 59. Europe Coagulation Albumin Sales Market Share by Application (2020-2025)
Figure 60. Germany Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 61. France Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Coagulation Albumin Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Coagulation Albumin Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Coagulation Albumin Sales Market Share by Application (2020-2025)
Figure 68. Egypt Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Coagulation Albumin Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Coagulation Albumin in 2025
Figure 74. Manufacturing Process Analysis of Coagulation Albumin
Figure 75. Industry Chain Structure of Coagulation Albumin
Figure 76. Channels of Distribution
Figure 77. Global Coagulation Albumin Sales Market Forecast by Region (2026-2031)
Figure 78. Global Coagulation Albumin Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Coagulation Albumin Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Coagulation Albumin Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Coagulation Albumin Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Coagulation Albumin Revenue Market Share Forecast by Application (2026-2031)